Clinical Trial Update: Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for high-risk neuroblastoma evaluating allogeneic tumor cell vaccination with oral metronomic cyclophosphamide (Phase 1/Phase 2); the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Allogeneic Tumor Cell Vaccination
• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Neuroblastoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING